UK secures £400 million investment to boost clinical trials
World-first public-private collaboration launched to kickstart economic growth and build an NHS fit for the future.
The Voluntary Scheme for Branded Medicine Pricing, Access, and Growth (VPAG) Investment Programme opens today. It will channel significant investment into the UK’s health and life sciences sector over the next five years, boosting economic growth and the global competitiveness of the UK’s life sciences sector.